| Entry |
|
|---|
| Name |
Dopamine (INN);
Medopa (TN)
|
|---|
| Formula |
C8H11NO2
|
|---|
| Exact mass |
153.079
|
|---|
| Mol weight |
153.1784
|
|---|
| Structure |
   |
|---|
| Simcomp |
 |
|---|
| Class |
Cardiovascular agent
DG01703 Cardiotonic
DG01699 Catecholamine cardiotonic
DG01592 COMT substrate
Neuropsychiatric agent
DG01472 Dopamine agonist
DG01467 Dopamine D1-receptor agonist
DG01468 Dopamine D2-receptor agonist
DG01469 Dopamine D3-receptor agonist
DG01470 Dopamine D4-receptor agonist
DG01471 Dopamine D5-receptor agonist
Metabolizing enzyme substrate
DG02917 MAO substrate
Transporter substrate
DG02854 SLC22A2 (OCT2) substrate
|
|---|
| Remark |
| Product (DG00213): | D00633<JP/US> |
|
|---|
| Efficacy |
Cardiotonic, Dopamine receptor agonist |
|---|
| Comment |
Catecholamine derivative
Precursor of Norepinephrine
Neurotransmitter
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Metabolism |
Enzyme: MAOB [HSA: 4129], COMT [HSA: 1312]
Transporter: SLC22A2 [HSA: 6582]
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07213 | Dopamine receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA04 Dopamine
D07870 Dopamine (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD
D07870 Dopamine (INN)
Prodrugs [br08324.html]
D07870
 |
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 11
1 C8y C 27.5800 -20.4400
2 C8x C 26.3200 -19.7400
3 C8x C 27.5800 -21.9100
4 C1b C 28.8400 -19.7400
5 C8y C 25.1300 -20.4400
6 C8x C 26.3200 -22.6100
7 C1b C 30.0300 -20.4400
8 C8y C 25.1300 -21.9100
9 O1a O 23.9400 -19.7400
10 N1a N 31.2200 -19.7400
11 O1a O 23.9400 -22.5400
BOND 11
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 5 8 1
8 5 9 1
9 7 10 1
10 8 11 1
11 6 8 2
|
|---|
